相似文献
1
Gabapentin for refractory pruritus in severe cutaneous adverse reactions.
JAAD Case Rep. 2025 Feb 21;59:4-5. doi: 10.1016/j.jdcr.2025.01.026. eCollection 2025 May.
2
Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020.
Med J Malaysia. 2022 Jul;77(4):409-414.
3
Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?
Orphanet J Rare Dis. 2012 Sep 25;7:72. doi: 10.1186/1750-1172-7-72.
4
Clinical features and prognostic factors of severe cutaneous adverse drug reactions: A single-center retrospective study of 209 cases in China.
Int Immunopharmacol. 2023 Jan;114:109530. doi: 10.1016/j.intimp.2022.109530. Epub 2022 Dec 9.
5
Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System.
Australas J Dermatol. 2024 May;65(3):243-253. doi: 10.1111/ajd.14262. Epub 2024 Apr 4.
6
Systematic review of BRAF/MEK inhibitors-induced Severe Cutaneous Adverse Reactions (SCARs).
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):607-614. doi: 10.1111/jdv.16894. Epub 2020 Sep 30.
7
A retrospective, 5-year, clinicoepidemiological study of severe cutaneous adverse reactions (SCARs).
Int J Dermatol. 2021 May;60(5):579-588. doi: 10.1111/ijd.15416. Epub 2021 Jan 17.
8
Antibiotic-induced severe cutaneous adverse reactions: a single-center retrospective study over ten years.
Front Immunol. 2024 Jul 18;15:1415830. doi: 10.3389/fimmu.2024.1415830. eCollection 2024.
9
Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System.
J Cutan Med Surg. 2024 Jan-Feb;28(1):51-58. doi: 10.1177/12034754231220931. Epub 2024 Jan 8.
10
Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Med Clin North Am. 2021 Jul;105(4):577-597. doi: 10.1016/j.mcna.2021.04.001.
本文引用的文献
1
Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics.
Front Pharmacol. 2022 Apr 20;13:832048. doi: 10.3389/fphar.2022.832048. eCollection 2022.
2
Current Perspectives on Severe Drug Eruption.
Clin Rev Allergy Immunol. 2021 Dec;61(3):282-298. doi: 10.1007/s12016-021-08859-0. Epub 2021 Jul 17.
3
Itch: From mechanism to (novel) therapeutic approaches.
J Allergy Clin Immunol. 2018 Nov;142(5):1375-1390. doi: 10.1016/j.jaci.2018.09.005.
4
Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review.
Br J Anaesth. 2018 Jun;120(6):1315-1334. doi: 10.1016/j.bja.2018.02.066. Epub 2018 Apr 12.
5
Gabapentin and pregabalin for the treatment of chronic pruritus.
J Am Acad Dermatol. 2016 Sep;75(3):619-625.e6. doi: 10.1016/j.jaad.2016.02.1237. Epub 2016 May 17.
Zotero 插件